BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Orphan Drugs Market Size, Shares and Trends | Growth Drivers | Forecast [2020-2030]

  The size of the orphan drugs market has been estimated to grow at a significant speed in the forthcoming years.

  May 30, 2022

   · 

  6 min read
• Policy

  Press Release: Update on Cialis® Rx-to-OTC Switch Actual Use Trial

  The U.S. Food and Drug Administration has informed Sanofi that its planned Actual Use Trial to support the Rx-to-OTC switch for Cialis® has been placed on clinical hold due to matters surrounding the protocol design.

  May 30, 2022

   · 

  4 min read
• Business

  Angle PLC Announces Partnership with Major United States Urology Group

  ANGLE plc is delighted to announce it has signed a master clinical study agreement with Solaris Health Holdings, LLC and joinder agreements with MidLantic Urology LLC, to collaborate and conduct clinical studies in prostate cancer and as a potential route to market in the United States.

  May 30, 2022

   · 

  11 min read
• Deals

  Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand

  Evotec SE announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price of € 23 m.

  May 30, 2022

   · 

  7 min read
• Genetown

  Presentation of Biomarker Analysis at ASCO

  Faron Pharmaceuticals Ltd announces that new biomarker data from patients treated with bexmarilimab as part of the ongoing phase I/II MATINS trial, will be presented at the upcoming American Society of Clinical Oncology 2022 Annual Meeting being held in Chicago, US from June 3 – 7.

  May 30, 2022

   · 

  11 min read
• Drug Development

  Pharnext Announces On-Schedule Completion of Patient Enrollment in its Pivotal Phase III Trial of PXT3003, the PREMIER Trial, for the Treatment of Charcot-Marie-Tooth Disease Type 1A

  Pharnext SA announces it has completed the enrollment of 387 patients in its pivotal Phase III clinical study of PXT3003, the PREMIER trial, in Charcot-Marie-Tooth disease type 1A.

  May 30, 2022

   · 

  6 min read
• Drug Development

  Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment

  Sirnaomics Ltd. announced the launch of a Phase I clinical trial of the Company’s siRNA drug candidate, STP705, in adults undergoing abdominoplasty for submental fat reduction.

  May 30, 2022

   · 

  4 min read
• Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth

  Avivagen Inc. is pleased to announce that it has signed a new distribution agreement with Nong San Viet Co., Ltd to support the company’s continued market expansion for its oxidized carotenoid-based feed additive product in Vietnam.

  May 30, 2022

   · 

  5 min read
• The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures

  Zelixir Biotech announces it has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes amid the recent emergence of monkeypox cases in Europe and the United States.

  May 30, 2022

   · 

  2 min read
• Business

  Covalon Announces Second Quarter Fiscal 2022 Results

  Covalon Technologies Ltd., an advanced medical technologies company, announced its second quarter fiscal 2022 results.

  May 30, 2022

   · 

  13 min read